Company SynAct Pharma AB

Equities

SYNACT

SE0008241491

Biotechnology & Medical Research

Business Summary

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Quarterly earnings - Rate of surprise

Sector Other Biotechnology & Medical Research

Market Closed - Nasdaq Stockholm Other stock markets 06:59:40 2024-04-30 am EDT			5-day change	1st Jan Change
6.84 ^SEK	-0.94%		-8.68%	-22.54%

Mar. 20	Sweden's SynAct Pharma Names New CEO	MT
Mar. 20	SynAct Pharma AB Elects New Board Members and Chairman at Extraordinary General Meeting	CI

SynAct Pharma AB is a manufacturer of biological products. The Company is located in Lund, Sweden. It develops medicines for acute impairment in inflammatory diseases. The company's drug candidate AP1189 is intended for the treatment of arthritis including psoriasis arthritis.

Number of employees: 5

Managers	Title	Age	Since
Björn Westberg DFI	Director of Finance/CFO	62	23-05-31
Kirsten Harting CTO	Chief Tech/Sci/R&D Officer	-	Feb. 14
Thomas Boesen COO	Chief Operating Officer	-	21-01-25
Thomas Jonassen CTO	Chief Tech/Sci/R&D Officer	-	-
James Knight PRN	Corporate Officer/Principal	-	21-02-10

Members of the board	Title	Age	Since
Thomas Jonassen CTO	Chief Tech/Sci/R&D Officer	-	-

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	35,570,980	25,196,609 ( 70.83 %)	0	70.83 %

Name	Equities	%	Valuation
Heights Capital Management, Inc. 10.54 %	3,750,000	10.54 %	3 M kr
TJ Biotech Invest APS 6.076 %	2,161,225	6.076 %	2 M kr
NORDNET AB 4.776 %	1,698,777	4.776 %	1 M kr
Ryan Quinn 4.217 %	1,500,000	4.217 %	1 M kr
Quantass Invest APS 3.853 %	1,370,419	3.853 %	1 M kr
GoodWind Holding GmbH 3.266 %	1,161,777	3.266 %	938 762 kr
Nils Thomas von Koch 3.144 %	1,118,210	3.144 %	903 558 kr
Torbjørn Bjerke 2.363 %	840,532	2.363 %	679 183 kr
Handelsbanken Fonder AB 1.240 %	441,077	1.240 %	356 408 kr
Henrik Stage 0.7457 %	265,264	0.7457 %	214 344 kr

SynAct Pharma AB

Scheelevägen 2

223 81, Lund

+46 1 03 00 10 23

http://www.synactpharma.com

Company calendar

Healthcare

Pharmaceuticals & Medical Research

Biotechnology & Medical Research

Biotechnology & Medical Research

Other Biotechnology & Medical Research

	1st Jan change	Capi.
SYNACT PHARMA AB	-22.54%	22.15M
IQVIA HOLDINGS INC.	+0.67%	42.19B
LONZA GROUP AG	+44.30%	40.15B
CELLTRION, INC.	-6.20%	28.31B
ICON PUBLIC LIMITED COMPANY	+6.55%	24.63B
ALNYLAM PHARMACEUTICALS, INC.	-21.66%	18.2B
MEDPACE HOLDINGS, INC.	+29.96%	12.01B
CHARLES RIVER LABORATORIES INTERNATIONAL, INC.	-1.57%	11.76B
UNITED THERAPEUTICS CORPORATION	+16.03%	10.4B
BIO-TECHNE CORPORATION	-4.80%	9.94B

Other Biotechnology & Medical Research